Calcitonin gene-related peptide: a potent dilator of human epicardial coronary arteries

Circulation. 1986 Dec;74(6):1243-7. doi: 10.1161/01.cir.74.6.1243.

Abstract

To investigate the action of calcitonin gene-related peptide (CGRP) on human epicardial coronary arteries, six patients received intracoronary CGRP at doses of 50,100, and 200 ng/min. The effect of CGRP was measured angiographically with a computerized analysis system. A dose-dependent increase in coronary arterial diameter was observed. At the highest dose there were 34%, 7%, 38%, and 40% mean increases in the diameters of the circumflex, proximal, mid, and distal left anterior descending arteries, respectively. No further increase in diameter was found after a subsequent dose of 1 mg intracoronary isosorbide dinitrate. Prior infusion of CGRP did not prevent coronary arterial spasm induced by ergonovine in two patients with variant angina, but a subsequent bolus of CGRP partially relieved the spasm. We propose that CGRP has a role in the regulation of coronary vascular smooth muscle tone.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angina Pectoris / diagnostic imaging
  • Angina Pectoris / drug therapy
  • Angina Pectoris, Variant / diagnostic imaging
  • Angina Pectoris, Variant / drug therapy
  • Calcitonin Gene-Related Peptide
  • Coronary Angiography
  • Coronary Vasospasm / chemically induced
  • Coronary Vasospasm / diagnostic imaging
  • Coronary Vasospasm / drug therapy
  • Coronary Vessels / drug effects*
  • Dose-Response Relationship, Drug
  • Drug Evaluation
  • Ergonovine
  • Female
  • Humans
  • Isosorbide Dinitrate / therapeutic use
  • Male
  • Middle Aged
  • Neuropeptides / therapeutic use*
  • Vasodilation / drug effects
  • Vasodilator Agents / therapeutic use*

Substances

  • Neuropeptides
  • Vasodilator Agents
  • Isosorbide Dinitrate
  • Calcitonin Gene-Related Peptide
  • Ergonovine